Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 15;5(1):129.
doi: 10.1186/s43058-024-00661-1.

Using an experience-based co-design approach to develop strategies for implementing an intravenous iron intervention to treat moderate and severe anemia in pregnancy in Malawi

Affiliations

Using an experience-based co-design approach to develop strategies for implementing an intravenous iron intervention to treat moderate and severe anemia in pregnancy in Malawi

Elisabeth Mamani-Mategula et al. Implement Sci Commun. .

Abstract

Background: In low- and middle-income countries, women experiencing anemia during pregnancy are recommended to take 30 mg to 60 mg of oral iron daily throughout pregnancy. However, oral iron tablets are often poorly tolerated and slow in correcting anemia, resulting in low adherence, prolonged anemia, and increased risk of adverse maternal and fetal outcomes. An alternative to oral iron is intravenous (IV) iron, commonly used in high-income countries to restore the body's iron stores rapidly. A randomized controlled trial was conducted to investigate the effectiveness and safety of IV iron compared to standard-of-care oral iron supplementation for pregnant women with moderate and severe anemia in the third trimester in Malawi (REVAMP-TT). Using an experience-based co-design approach, our study aimed to identify barriers and facilitators to IV iron use to treat anemia in pregnancy in the primary healthcare system of Malawi, and develop mitigating strategies for the successful implementation of REVAMP-TT.

Methodology: The co-design process involved two phases: i) We conducted an information-gathering exercise to identify barriers and facilitators to IV iron use to treat anemia in pregnancy in the primary healthcare system of Malawi. We interviewed key informants (n = 53) including the policymakers, government partners, healthcare managers, and healthcare providers. We also gathered previous research findings from a formative qualitative study on the perceptions and experiences of IV iron treatment for pregnant women experiencing anemia in Malawi (n = 29). ii) We conducted two co-design workshops with end-users (n = 20) and healthcare providers (n = 20) to confirm and identify the key barriers and facilitators and developed mitigating strategies to inform the successful implementation of the REVAMP-TT trial. We mapped the emerging barriers to the Consolidated Framework for Implementation Research 2.0 (CFIR 2.0) and matched the mitigating strategies to the corresponding Expert Recommendations for Implementing Change (ERIC) compilation.

Results: The following were identified as key barriers to IV iron use to treat anemia in pregnancy in the primary healthcare system of Malawi: the cost of IV iron, the lack of available resources and knowledge, local attitudes including myths and misconceptions about IV iron and keeping pregnancy a secret, local conditions, the lack of political will and buy-in from high-level leaders, the lack of capability of healthcare providers to deliver IV iron, and the lack of male involvement to support pregnant women's access to antenatal care. The proposed strategies to mitigate the barriers for the successful implementation of the REVAMP TT trial included providing financial strategy, developing stakeholder relationships, training and educating stakeholders, supporting clinicians, and engaging end-users.

Conclusion: The use of the experience-based co-design approach in our study provided a valuable method to expose the potential barriers and facilitators to IV iron use and develop mitigating strategies to successfully implement the REVAMP-TT trial. Engaging both the key informants and end users promoted ownership and consensus among stakeholders and ensured a collaborative environment for sharing deeply rooted real-world experiences and insights. Not only do these findings address the needs of this study, but they also, lay a groundwork for the possible integration of IV iron into routine care in Malawi and provide knowledge for policymakers to make informed decisions on the management of anemia in the primary healthcare systems of Malawi.

Keywords: Anemia; Antenatal care; Community engagement; Experience-based co-design; Implementation strategies; Intravenous iron; Pregnant women.

PubMed Disclaimer

Conflict of interest statement

Declarations Ethics approval and consent to participate We received ethics approval (P.08/20/3114) from the University of Malawi’s College of Medicine Research and Ethics Committee. All participants signed the informed consent form. Consent for publication Not applicable. Competing interests We know of no conflicts of interest associated with this publication.

Figures

Fig. 1
Fig. 1
Experience-based co-design orientation and collaborative change processes
Fig. 2
Fig. 2
Key barriers mapped to selected implementation strategies in an implementation research logic model
Fig. 3
Fig. 3
Information, education and communication wallchart for anemia in pregnancy (English Version)
Fig. 4
Fig. 4
Information, education and communication poster for anemia in pregnancy (English Version)
Fig. 5
Fig. 5
Information, education, and communication wallchart for anemia in pregnancy (Chichewa version)
Fig. 6
Fig. 6
Information, education, and communication poster for anemia in pregnancy (Chichewa version)

Similar articles

References

    1. Vitamin and Mineral Nutrition Information System (VMNIS). WHO global database on Anaemia The database on Anaemia includes data by country on prevalence of anaemia and mean haemoglobin concentration. 2007.
    1. Gebreweld A, Tsegaye A. Prevalence and Factors Associated with Anemia among Pregnant Women Attending Antenatal Clinic at St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia. Adv Hematol. 2018;2018:3942301. - PMC - PubMed
    1. Vanobberghen F, Lweno O, Kuemmerle A, Mwebi KD, Asilia P, Issa A, et al. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial. Lancet Glob Health. 2021;9(2):e189–98. - PubMed
    1. Jericó C, Beverina I, Quintana-Diaz M, Salvadori U, Melli C, Rondinelli MB, Recasens V, Brando B, Garcia-Erce JA. Efficacy and safety of high-dose intravenous iron as the first-choice therapy in outpatients with severe iron deficiency anemia. Transfusion. 2020;60(7):1443–9. 10.1111/trf.15870. Epub 2020 Jun 29. - PubMed
    1. Tigga M, Debbarma A. A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast India. Tzu Chi Med J. 2020;32(3):258–61. - PMC - PubMed

LinkOut - more resources